Pseudovirus News and Research

RSS
Exploring the potential utility of calcium channel inhibitors in SARS-CoV-2 infection

Exploring the potential utility of calcium channel inhibitors in SARS-CoV-2 infection

Study reports of receptor-binding domain multimer capable of enhancing the immune response against SARS-CoV-2

Study reports of receptor-binding domain multimer capable of enhancing the immune response against SARS-CoV-2

Three doses Of Pfizer-BioNTech vaccine could offer sufficient level of protection from Omicron

Three doses Of Pfizer-BioNTech vaccine could offer sufficient level of protection from Omicron

Exploring SARS-CoV-2 Omicron variant’s neutralizing capacity of booster vaccines

Exploring SARS-CoV-2 Omicron variant’s neutralizing capacity of booster vaccines

Study demonstrates that intra-host SARS-CoV-2 variants with reduced infectivity are developed during infection

Study demonstrates that intra-host SARS-CoV-2 variants with reduced infectivity are developed during infection

Hollow fiber membranes efficiently remove synthetic SARS-CoV-2 from the air

Hollow fiber membranes efficiently remove synthetic SARS-CoV-2 from the air

Cannabinoids may prevent infection with SARS-CoV-2, including variants

Cannabinoids may prevent infection with SARS-CoV-2, including variants

An egg-derived SARS-CoV-2 vaccine and treatment for COVID-19 disease

An egg-derived SARS-CoV-2 vaccine and treatment for COVID-19 disease

Isolated antibodies from BNT162b2 vacinee effective against Omicron variant

Isolated antibodies from BNT162b2 vacinee effective against Omicron variant

Engineered small extracellular vesicles for the neutralization of SARS-CoV-2

Engineered small extracellular vesicles for the neutralization of SARS-CoV-2

Broad cross-neutralization antibodies found to be effective against SARS-CoV-2 Omicron variant

Broad cross-neutralization antibodies found to be effective against SARS-CoV-2 Omicron variant

SARS-CoV-2 Omicron belongs to new antigenic cluster compared to all other VOCs

SARS-CoV-2 Omicron belongs to new antigenic cluster compared to all other VOCs

Small molecule identified as a SARS-CoV-2 inhibitor

Small molecule identified as a SARS-CoV-2 inhibitor

Comparison of neutralization of SARS-CoV-2 variants of concern Omicron and Delta

Comparison of neutralization of SARS-CoV-2 variants of concern Omicron and Delta

COVID boosters hinder SARS-CoV-2 Omicron

COVID boosters hinder SARS-CoV-2 Omicron

Integrin/TGF-β1 inhibitors highly effective in attenuating COVID-19 severity

Integrin/TGF-β1 inhibitors highly effective in attenuating COVID-19 severity

Exploring SARS-CoV-2-like viruses to mitigate the risk of zoonotic transmission to humans

Exploring SARS-CoV-2-like viruses to mitigate the risk of zoonotic transmission to humans

Exploring vaccine-induced cellular immunity against SARS-CoV-2 Omicron variant

Exploring vaccine-induced cellular immunity against SARS-CoV-2 Omicron variant

mRNA booster vaccine confers strong protection against SARS-CoV-2 Omicron in cancer patients

mRNA booster vaccine confers strong protection against SARS-CoV-2 Omicron in cancer patients

Scientists provide a structural framework for Omicron immune evasion and ACE2 receptor recognition

Scientists provide a structural framework for Omicron immune evasion and ACE2 receptor recognition